Sight Sciences (SGHT) News Today $3.80 -0.06 (-1.55%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Sight Sciences FY2024 EPS Estimate Lifted by William BlairNovember 15 at 2:31 AM | americanbankingnews.comWilliam Blair Expects Increased Earnings for Sight SciencesSight Sciences, Inc. (NASDAQ:SGHT - Free Report) - Research analysts at William Blair raised their FY2024 earnings per share (EPS) estimates for shares of Sight Sciences in a research report issued on Monday, November 11th. William Blair analyst M. Andrew now forecasts that the company will postNovember 13, 2024 | marketbeat.comMorgan Stanley Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00November 13, 2024 | americanbankingnews.comSight Sciences price target lowered to $5 from $7 at Morgan StanleyNovember 11, 2024 | markets.businessinsider.comMorgan Stanley Issues Pessimistic Forecast for Sight Sciences (NASDAQ:SGHT) Stock PriceMorgan Stanley dropped their target price on shares of Sight Sciences from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research note on Monday.November 11, 2024 | marketbeat.com'A direct relationship between your sense of sight and recovery rate': Biologist Kathy Willis on why looking at nature can speed up healingNovember 10, 2024 | msn.comSight Sciences Reports Modest Growth and Optimistic OutlookNovember 9, 2024 | markets.businessinsider.comSight Sciences price target lowered to $5.50 from $6 at Piper SandlerNovember 9, 2024 | markets.businessinsider.comSight Sciences, Inc. (SGHT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comSight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...November 8, 2024 | finance.yahoo.comSight Sciences (NASDAQ:SGHT) Earns Neutral Rating from Piper SandlerPiper Sandler reissued a "neutral" rating and set a $5.50 price objective (down from $6.00) on shares of Sight Sciences in a research note on Friday.November 8, 2024 | marketbeat.comSight Sciences' (SGHT) "Hold" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Sight Sciences in a report on Friday.November 8, 2024 | marketbeat.comSight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense GuidanceNovember 8, 2024 | markets.businessinsider.comSight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, OperationsNovember 8, 2024 | finance.yahoo.comSight Sciences downgraded to Hold from Buy at Lake StreetNovember 5, 2024 | markets.businessinsider.comSight Sciences (NASDAQ:SGHT) Downgraded to Hold Rating by Lake Street CapitalLake Street Capital cut Sight Sciences from a "buy" rating to a "hold" rating and reduced their price target for the company from $10.00 to $5.00 in a research report on Monday.November 4, 2024 | marketbeat.comMatthew Link Sells 21,831 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockOctober 22, 2024 | insidertrades.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Matthew Link sold 21,831 shares of the company's stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $5.61, for a total value of $122,471.91. Following the completion of the transaction, the insider now directly owns 663,550 shares of the company's stock, valued at $3,722,515.50. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.October 21, 2024 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 SharesOctober 19, 2024 | insidertrades.comSight Sciences to Report Third Quarter Financial Results on November 7, 2024October 17, 2024 | globenewswire.comLake Street Sticks to Its Buy Rating for Sight Sciences (SGHT)October 15, 2024 | markets.businessinsider.comSight Sciences: TearCare Treatment Enhances Visual Outcomes And Symptoms In Dry Eye Disease TrialOctober 15, 2024 | markets.businessinsider.comSingle TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated TrialOctober 14, 2024 | globenewswire.comRenaissance Technologies LLC Has $461,000 Stake in Sight Sciences, Inc. (NASDAQ:SGHT)Renaissance Technologies LLC cut its holdings in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 60.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,100 shares of the company's stock after seOctober 11, 2024 | marketbeat.comSight Sciences (NASDAQ:SGHT) Stock, Short Interest ReportOctober 7, 2024 | benzinga.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $18,970.33 in StockOctober 4, 2024 | insidertrades.comB. Riley Wealth Advisors Inc. Acquires Shares of 185,082 Sight Sciences, Inc. (NASDAQ:SGHT)B. Riley Wealth Advisors Inc. bought a new position in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 185,082 shares of the company's stock, valued at approximOctober 4, 2024 | marketbeat.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,167 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 3,167 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $5.99, for a total value of $18,970.33. Following the sale, the chief technology officer now owns 1,756,481 shares of the company's stock, valued at $10,521,321.19. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.October 4, 2024 | marketbeat.comLake Street Keeps Their Buy Rating on Sight Sciences (SGHT)October 3, 2024 | markets.businessinsider.comEye exercises to improve sight – is there any science behind them? An ophthalmologist explains why you shouldn’t buy the hypeSeptember 30, 2024 | msn.comInstitutional investors own a significant stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)September 30, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: Bioventus (BVS), Sight Sciences (SGHT)September 28, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) Position Raised by Long Focus Capital Management LLCLong Focus Capital Management LLC increased its holdings in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 86.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 560,594 shares of the company's sSeptember 27, 2024 | marketbeat.comSight Care: Key Insights From Our Expert Review (Customers Beware)September 18, 2024 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by BrokeragesShares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have been given an average recommendation of "Hold" by the eight research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have aSeptember 7, 2024 | marketbeat.comSight Sciences: A Balanced View Amidst Recovery and UncertaintiesSeptember 6, 2024 | markets.businessinsider.comLake Street Initiates Coverage of Sight Sciences (SGHT) with Buy RecommendationAugust 22, 2024 | msn.comSight Sciences (NASDAQ:SGHT) Now Covered by Lake Street CapitalLake Street Capital began coverage on shares of Sight Sciences in a research report on Wednesday. They set a "buy" rating and a $10.00 price target for the company.August 21, 2024 | marketbeat.comSight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare ConferenceAugust 20, 2024 | globenewswire.comSGHT Sep 2024 10.000 call (SGHT240920C00010000)August 19, 2024 | finance.yahoo.comHold Rating on SGHT Amid Balanced Prospects and Pricing ConcernsAugust 3, 2024 | markets.businessinsider.comSight Sciences, Inc. (SGHT) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | seekingalpha.comSight Sciences (NASDAQ:SGHT) Issues Quarterly Earnings ResultsSight Sciences (NASDAQ:SGHT - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share for the quarter, beating analysts' consensus estimates of ($0.31) by $0.06. Sight Sciences had a negative net margin of 67.18% and a negative return on equity of 44.45%. The business had revenue of $21.37 million during the quarter, compared to analyst estimates of $21.32 million. During the same period in the previous year, the business earned ($0.30) EPS.August 2, 2024 | marketbeat.comSight Sciences (NASDAQ:SGHT) Rating Reiterated by Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Sight Sciences in a research note on Friday.August 2, 2024 | marketbeat.comSight Sciences, Inc.: Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial GuidanceAugust 2, 2024 | finanznachrichten.deJacobs Levy Equity Management Inc. Buys 76,549 Shares of Sight Sciences, Inc. (NASDAQ:SGHT)Jacobs Levy Equity Management Inc. raised its stake in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 25.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 377,057 shares of the company's stock after buying an additionalAugust 1, 2024 | marketbeat.comWhat Wall Street expects from Sight Sciences's earningsJuly 31, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) Short Interest UpdateSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,300,000 shares, an increase of 20.4% from the June 30th total of 1,080,000 shares. Approximately 4.9% of the shares of the company are short sold. Based on an average trading volume of 181,000 shares, the days-to-cover ratio is presently 7.2 days.July 28, 2024 | marketbeat.comC-Suite Awards 2024: Ingrid Schunder of Miracles in SightJuly 25, 2024 | bizjournals.comSight Sciences (SGHT) Set to Announce Quarterly Earnings on ThursdaySight Sciences (NASDAQ:SGHT) will be releasing earnings after the market closes on Thursday, August 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=610495)July 25, 2024 | marketbeat.com Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy. SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼0.440.56▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼112▲SGHT Articles Average Week Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRDX News OFIX News BVS News AVNS News EMBC News CATX News LQDA News KIDS News IRMD News AXGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
